Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SGS Expands E&L Capacity | Contract Pharma
Breaking News

SGS Expands E&L Capacity

Two additional instruments have been installed and validated

SGS, an analytical and bioanalytical contract services provider, has made additional investments at its lab in Fairfield, NJ, to increase services and capacity to support extractables and leachables (E&L) testing for the pharma and biopharma industries. At the company’s North American CoE for E&L, two additional instruments have been installed and validated, and SGS will hire additional analysts dedicated to these services.
 
The new instruments, an LC-MS/MS, and GC-MS with head-space capability, are both high resolution and high throughput systems, allowing for improved and rapid identification of trace unknown extractable compounds. The lab currently offers testing facilities for a wide range of E&L applications, including final pharmaceutical packaging, single-use systems and medical devices.
 
“SGS has seen a rise in the demand for services in this area, and we have invested significantly across our global network to ensure that we can maintain our strong reputation for extractables and leachables testing expertise,” said Kelly Bertrand, general manager of SGS’s Fairfield facility. “The additional capabilities we have now at Fairfield allow us to overcome greater analytical challenges for our existing clients, and ensure we can remain competitive and have the capacity to attract new customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters